GLP-Tirz 10/30/60MG

Tirzepatide is a dual GIP and GLP-1 receptor agonist studied for its potent effects on weight reduction and glycemic control.

• May support substantial reductions in body weight
• Studied for its role in blood sugar regulation and glycemic control
• Research suggests improvements in cardiovascular risk markers
• Potential benefits in appetite suppression and metabolic health

For research purposes only. Not intended for human consumption, veterinary use, or any purpose other than in vitro scientific research. These statements have not been evaluated by the FDA.